New Stanford Treatment Study Focused on Fragile X Syndrome
Adolescents and Young Adults with Fragile X Syndrome Age 12-29 Years Needed
We are recruiting females and males between the ages of 12 and 29 years to participate in a newly funded medication study in Fragile X syndrome.
Participants will have the opportunity to receive the medication, donepezil, which may improve cognition and behavior in individuals with this important condition. This study is funded by the National Institute of Mental Health and Autism Speaks and is being conducted at Stanford University School of Medicine.
- Cognitive and behavioral testing
- MRI scan
- Free study medication for 12 weeks
Benefits of participating:
- Potential improvement in behavior and/or cognition
- You will receive an honorarium of $100 for your participation
- Cognitive and behavioral assessment reports
For more information, or to enroll, contact:
firstname.lastname@example.org or (650) 704-9763
For further information regarding questions, concerns, or complaints about research, research related injury, and questions about the rights of research participants, please call (650) 723-5244 or call toll free (866) 680-2906 or write the Administrative Panel on Human Subjects in Medical Research, Administrative Panels Office, Stanford University, Stanford, CA 94305-5401.
IRB Protocol 13773 (approved 5/24/11-5/24/12)